Table 1.

Summary of the Polymorphism Analysis as Performed for Patient (A.P.) and His Parents

PolymorphismsPatient (A.P.) Mother (M.P.)Father (F.P.)
DNA cDNA DNA cDNADNA cDNA
HPA-1  a/b  a  a  a  a/b  a/b 
TaqI  −/+  −  −  −  +  
HPA-3  a/b  a  a/b  a  a  a  
Exon 30  2/3 3  1/2  1  1/3  1/3  
Del  −/+  NA  −/+ NA  −  NA 
PolymorphismsPatient (A.P.) Mother (M.P.)Father (F.P.)
DNA cDNA DNA cDNADNA cDNA
HPA-1  a/b  a  a  a  a/b  a/b 
TaqI  −/+  −  −  −  +  
HPA-3  a/b  a  a/b  a  a  a  
Exon 30  2/3 3  1/2  1  1/3  1/3  
Del  −/+  NA  −/+ NA  −  NA 

Analysis of different polymorphisms on DNA was performed using ASRA, SSCP, or DNA sequencing. The detection of the polymorphisms on RNA was performed using the same methods after RT-PCR. HPA-1 andTaqI polymorphisms are carried on the β3 gene and HPA-3, exon 30 polymorphisms, and Del are carried on the αIIb gene. For TaqI: − refers to the absence of digestion and + to digestion by the TaqI restriction enzyme. For Exon 30: 1 refers to the wild-type published sequence; 2 to the silent mutation, C to T, in the codon for Val990; and 3 to the G to A mutation responsible for the Arg995 to Gln amino acid substitution. Del: − and + refer, respectively, to the absence or presence of a 9-bp deletion in intron 21 of the αIIb gene. This 9-bp deletion is observed in HPA-3b individuals only.

Abbreviation: NA, not available for study on cDNA because this polymorphism is located in an intron.